AU2653095A - Fibroblast growth factor-14 - Google Patents

Fibroblast growth factor-14

Info

Publication number
AU2653095A
AU2653095A AU26530/95A AU2653095A AU2653095A AU 2653095 A AU2653095 A AU 2653095A AU 26530/95 A AU26530/95 A AU 26530/95A AU 2653095 A AU2653095 A AU 2653095A AU 2653095 A AU2653095 A AU 2653095A
Authority
AU
Australia
Prior art keywords
growth factor
fibroblast growth
fibroblast
factor
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU26530/95A
Other versions
AU702131B2 (en
Inventor
Patrick J. Dillon
John M Greene
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU2653095A publication Critical patent/AU2653095A/en
Application granted granted Critical
Publication of AU702131B2 publication Critical patent/AU702131B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/50Fibroblast growth factor [FGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU26530/95A 1995-06-05 1995-06-05 Fibroblast growth factor-14 Ceased AU702131B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1995/006730 WO1996039506A1 (en) 1995-06-05 1995-06-05 Fibroblast growth factor-14
CA002212992A CA2212992A1 (en) 1995-06-05 1995-06-05 Fibroblast growth factor-14

Publications (2)

Publication Number Publication Date
AU2653095A true AU2653095A (en) 1996-12-24
AU702131B2 AU702131B2 (en) 1999-02-11

Family

ID=25679546

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26530/95A Ceased AU702131B2 (en) 1995-06-05 1995-06-05 Fibroblast growth factor-14

Country Status (4)

Country Link
EP (1) EP0833904A4 (en)
AU (1) AU702131B2 (en)
CA (1) CA2212992A1 (en)
WO (1) WO1996039506A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073452A2 (en) * 1999-06-02 2000-12-07 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US6787640B2 (en) 1995-06-05 2004-09-07 Human Genome Sciences, Inc. Fibroblast growth factor 14
CA2249179A1 (en) * 1996-03-21 1997-09-25 The Johns Hopkins University School Of Medicine Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use
US6020189A (en) * 1996-08-30 2000-02-01 The Johns Hopkins University School Of Medicine Fibroblast growth factor homologous factors (FHFs) and methods of use
CN1311212A (en) * 2000-03-02 2001-09-05 上海博德基因开发有限公司 New polypeptide-human fibroblastic growth factor 14 and polynucleotide for coding said polypeptide
EP1977004B1 (en) 2005-12-02 2014-10-29 The Scripps Research Institute Angiogenic tyrosyl trna synthetase compositions and methods
AU2011289833C1 (en) 2010-07-12 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Histidyl-tRNA synthetases
EP2608801B1 (en) 2010-08-25 2019-08-21 aTyr Pharma, Inc. INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES
WO2013022982A2 (en) 2011-08-09 2013-02-14 Atyr Pharma, Inc. Pegylated tyrosyl-trna synthetase polypeptides
NZ628126A (en) 2012-02-16 2016-10-28 Atyr Pharma Inc Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
DK3460054T3 (en) 2013-03-15 2021-01-18 Atyr Pharma Inc Histidyl-tRNA-synthetase-Fc conjugates
CA3060514A1 (en) 2017-04-20 2018-10-25 Atyr Pharma, Inc. Compositions and methods for treating lung inflammation

Also Published As

Publication number Publication date
CA2212992A1 (en) 1996-12-12
WO1996039506A1 (en) 1996-12-12
EP0833904A1 (en) 1998-04-08
EP0833904A4 (en) 2000-05-17
AU702131B2 (en) 1999-02-11

Similar Documents

Publication Publication Date Title
AU5235796A (en) o-hydroxyphenyl-s-triazines
AU4780896A (en) Core-board
AU6000496A (en) Phenylpyridazinones
AU5896396A (en) Pyridine-microbicides
AU1030997A (en) Taphane
AU4996696A (en) 2-benzyl-3-arylbenzothiophenes
AU2653095A (en) Fibroblast growth factor-14
AU2653195A (en) Fibroblast growth factor 11
AU5593896A (en) Benzisothiazolyl-substituted aminomethylchromans
AU5500196A (en) Anti-transpirants
AU4382896A (en) Acetylimidazobenzodiazepines
AU2697995A (en) Fibroblast growth factor 13
AU5108596A (en) Morphine-3-esters
AU1041297A (en) Fibroblast growth factor fgf-10
AU5917896A (en) Poly-beta-1-4-N-acetylglucosamine
AU6215196A (en) Piperidinylmethyloxazolidinones
AU5013796A (en) Wireclamp
AU5107096A (en) Haemodialyser
AU5433798A (en) Fibroblast growth factor-13
AU4569496A (en) Tetralinyl- and indanyl-ethylamides
AU5527296A (en) Growth factor htter36
AU2609095A (en) Compartmentalizer
AU4531096A (en) Foodpellet
AU2161897A (en) Helicopter-airplane
AU4831396A (en) Pyrazolotetracyclines